With the biopharmaceutical world still buzzing from the latest data presented at the American Society of Hematology meeting, we sat down with industry expert Ivan Kairatov to unpack the results that have sent one company's stock soaring. At the center of the discussion is TERN-701, an experimental
Allow me to introduce Ivan Kairatov, a distinguished biopharma expert whose innovative research and development work has significantly advanced our understanding of cellular signaling and protein interactions. With a profound focus on transporter regulation, Ivan has been at the forefront of
Imagine a world where a single shot at birth could shield a child from a devastating liver disease, yet the decision to administer it hangs in a delicate balance of science, public opinion, and political will. In the United States, the hepatitis B vaccine, a cornerstone of infant health for over
Imagine a world where a single drug could shift the trajectory of blood cancer treatment, offering hope to thousands battling chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). At the recent American Society of Hematology (ASH) meeting in Orlando, Eli Lilly thrust its BTK
Allow me to introduce Ivan Kairatov, a seasoned biopharma expert whose extensive background in technology and innovation has positioned him at the forefront of groundbreaking developments in genetic medicine. With years of experience in research and development, Ivan has been closely following the
As I sit down with Ivan Kairatov, a renowned biopharma expert with a passion for cutting-edge technology and innovation, I’m eager to dive into the transformative potential of sweat as a diagnostic biofluid. With years of experience in research and development, Ivan has been at the forefront of
